Title : Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity - Rodriguez-Mortera_2020_Clin.Chim.Acta_508_61 |
Author(s) : Rodriguez-Mortera R , Caccavello R , Garay-Sevilla ME , Gugliucci A |
Ref : Clinica Chimica Acta , 508 :61 , 2020 |
Abstract :
BACKGROUND: We hypothesized that adolescents with obesity have higher remnant B48 concentrations associated with lipoprotein lipase dysregulation. METHODS: Cross-sectional study of 32 adolescents with obesity and 27 control subjects. RESULTS: As compared to lean controls, obese participants showed 35% higher concentrations of apoB48: 3.60 (2.93-4.30) vs 2.65 (1.64-3.68) ng/ml; 28% of apoC-III: (72.7 (58.6-89.7) vs 56.9 (44.8-79.8 ug/ml and 17% ANGPTL 3: (72.2 +/- 20.2 vs 61.2 +/- 19.2 ng/ml). This was accompanied by a 33% reduction in LPL: 13.1 +/- 5.1 vs 18.9 +/- 4.7 ng/ml. Obese participants had 25% lower adiponectin 2.9 (1.9-3.8) vs 4.4 (3.2.-5.2) mug/ml; 260% higher leptin 25.7 (11.2-44.8) vs 9.3 (2.8-20.7) ng/ml (c) and 83% higher Il-6: 2.2 (1.3-5.4) vs 1.2 (0.8-1.4) pg/ml. ApoC-III and ANGPTL3 correlated positively with VAI; ANGPTL3 negatively with HDL-C; LDL size and VLDL-C. ApoB48 correlated negatively with LDL-C. CONCLUSIONS: Adolescents with obesity show higher ANGPTL3 compounded with increased apoC-III associated with increased CR and lower LPL mass. This is associated with inflammation and visceral fat. The significance of these findings resides in that they shed light on a mechanism for TRL dyslipidemia in adolescents: increased LPL inhibition impairs VLDL and chylomicron catabolism leading to atherogenic remnants. |
PubMedSearch : Rodriguez-Mortera_2020_Clin.Chim.Acta_508_61 |
PubMedID: 32407781 |
Rodriguez-Mortera R, Caccavello R, Garay-Sevilla ME, Gugliucci A (2020)
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity
Clinica Chimica Acta
508 :61
Rodriguez-Mortera R, Caccavello R, Garay-Sevilla ME, Gugliucci A (2020)
Clinica Chimica Acta
508 :61